Carlyle Group Inc. - Q1 2016 holdings

$7.98 Billion is the total value of Carlyle Group Inc.'s 31 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 25.0% .

 Value Shares↓ Weighting
TERP SellTerraForm Pwr Inc$26,095,000
-40.1%
3,016,800
-12.9%
0.33%
-43.1%
CREG SellChina Recycling Energy Corp$1,559,000
-20.9%
5,102,666
-7.3%
0.02%
-23.1%
MPOYQ SellMidstates Pete Co Inc$696,000
-88.2%
1,960,265
-33.2%
0.01%
-88.5%
SQBG ExitSequential Brands Group Inc$0-6,369,812
-100.0%
-0.66%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
1Life Healthcare IncFebruary 11, 202213,612,6817.1%
Atotech LtdFebruary 11, 2022153,672,70378.9%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-06-27
42024-06-25
SC 13D/A2024-06-25
42024-06-21
42024-06-18
42024-06-14
8-K2024-05-31
42024-05-23
42024-05-23
42024-05-23

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings